Malin Grönberg
Researcher at Department of Medical Sciences; Endocrine Oncology
- E-mail:
- Malin.Gronberg@medsci.uu.se
- Visiting address:
- Rudbecklaboratoriet, R3, vån 2
SE-75185 Uppsala
Sweden - Postal address:
- Rudbecklaboratoriet, R3, vån 2
SE-75185 Uppsala
Sweden
- ORCID:
- 0000-0003-4001-0572
Keywords
- cancer
- peptides
- research
- neuroendocrine cancer
- hormon
- ghrelin
Biography
My basic education is a M.Sc. in Biotechnology from SLU/Uppsala University.
I performed my Ph.D. in the field of Medical sciences at Uppsala University.
Research
Research concerning the expression and function of different peptide hormones in normal and neoplastic tissue.
Publications
Recent publications
-
Part of Journal of neuroendocrinology, 2025
- DOI for Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
- Download full text (pdf) of Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
-
Comparison of two prognostic models for the treatment of pancreatic NET with PRRT
Part of Journal of neuroendocrinology, 2025
-
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
Part of Endocrine-Related Cancer, 2023
- DOI for Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
- Download full text (pdf) of Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
-
Part of Journal of neuroendocrinology, 2021
-
Part of Endocrine, p. 893-904, 2021
- DOI for Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
- Download full text (pdf) of Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
All publications
Articles in journal
-
Part of Journal of neuroendocrinology, 2025
- DOI for Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
- Download full text (pdf) of Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
-
Comparison of two prognostic models for the treatment of pancreatic NET with PRRT
Part of Journal of neuroendocrinology, 2025
-
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
Part of Endocrine-Related Cancer, 2023
- DOI for Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
- Download full text (pdf) of Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
-
Part of Journal of neuroendocrinology, 2021
-
Part of Endocrine, p. 893-904, 2021
- DOI for Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
- Download full text (pdf) of Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
-
Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome
Part of Hormones, p. 351-360, 2020
- DOI for Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome
- Download full text (pdf) of Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome
-
Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
Part of Scientific Reports, 2020
- DOI for Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
- Download full text (pdf) of Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
-
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
Part of PLOS ONE, 2020
- DOI for PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
- Download full text (pdf) of PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
-
Ghrelin expression is associated with a favorable outcome in male breast cancer
Part of Scientific Reports, 2018
- DOI for Ghrelin expression is associated with a favorable outcome in male breast cancer
- Download full text (pdf) of Ghrelin expression is associated with a favorable outcome in male breast cancer
-
Part of Medical Oncology, 2018
- DOI for Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
- Download full text (pdf) of Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
-
Part of Neuroendocrinology, p. 184-184, 2018
-
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
Part of PLOS ONE, 2017
- DOI for Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
- Download full text (pdf) of Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
-
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
Part of PLOS ONE, 2017
- DOI for Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
- Download full text (pdf) of Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
-
A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
Part of Endocrine-Related Cancer, p. 427-443, 2017
- DOI for A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
- Download full text (pdf) of A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
-
Expression of Mutated p53 Protein in Gastroenteropancreatic Neuroendocrine Carcinoma (WHO G3)
Part of Neuroendocrinology, p. 43-43, 2016
-
Part of Neuroendocrinology, p. 291-299, 2013
- DOI for Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake
- Download full text (pdf) of Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake
-
Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer
Part of Acta Oncologica, p. 386-393, 2012
-
Neuroendocrine markers are expressed in human mammary glands
Part of Regulatory Peptides, p. 68-74, 2010
-
Part of Anticancer Research, p. 1859-1866, 2009
-
Part of Journal of Histochemistry and Cytochemistry, p. 793-801, 2008
-
Somatostatin induces rapid contraction of neuroendocrine cells
Part of FEBS Letters, p. 1957-1962, 2007